13 Points to Consider When Considering the Purchase of a Filter Integrity Testing Device
We have prepared a "Selection Guide (Japanese version)" that summarizes 13 key points to keep in mind when choosing a filter integrity testing device. If you thoroughly consider and define what the important evaluation criteria are and which items can be compromised before making an actual selection, you will only need to gather information and compare it based on the defined evaluation criteria. It also includes points that are often overlooked during device selection, so please make use of it when considering your options!
Inquire About This Product
basic information
The recommendations from regulatory authorities regarding filter integrity testing have been expanding, and for filters used in critical applications, integrity testing has become mandatory. By introducing equipment based on sufficient information and proper evaluation and consideration, seamless integration with devices used in critical processes can be achieved, enabling trouble-free operation for many years. This selection guide outlines the conditions for conducting high-precision filter integrity tests in compliance with current regulations to ensure patient safety, as well as the items to confirm when selecting appropriate filter integrity testing equipment. Please make use of this during equipment comparisons and selections!
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the relevant materials or feel free to contact us.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.